Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 6, 2002, Pages 934-939

  Fay, William P ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Neointima; Plasminogen activator inhibitor 1; Vascular biology; Vascular smooth muscle cells; Vitronectin

Indexed keywords

ACTIVATED PROTEIN C; FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; VITRONECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD CLOT LYSIS; BLOOD VESSEL INJURY; BLOOD VESSEL OCCLUSION; CAROTID ARTERY; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBRIN DEPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL LINE; CELL MOVEMENT; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; TUNICA INTIMA; VITRONECTIN;

EID: 0036077426     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000019360.14554.53     Document Type: Article

References (33)

1. Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension
2. Role of vitronectin and its receptors in haemostasis and vascular remodeling
3. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma
4. Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix
5. Thrombin regulation by physiological inhibitors: The role of vitronectin
6. Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1
7. Stimulation of migration of human aortic smooth muscle cells by vitronectin: Implications for atherosclerosis
8. Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor
9. Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-tyk2 interaction
10. Vitronectin is not essential for normal mammalian development and fertility
11. Plasminogen activator inhibitor-1 gene deficient mice, I: Generation by homologous recombination and characterization
12. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow
13. Vascular wound healing and neointima formation induced by penvascular electric injury in mice
14. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice
15. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice
16. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice
17. Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development
18. Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin
19. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity
20. The activated protein C-mediated enhancement of tissue-type plasminogen activator-induced fibrinolysis in a cell-free system
21. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice
22. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants
23. Molecular evolution of plasminogen activator inhibitor-1 functional stability
24. The serpin PAI-1 inhibits cell migration by blocking integrin alpha-V beta-3 binding to vitronectin
25. Integrin-mediated mechanotransduction in vascular smooth muscle cells: Frequency and force response characteristics
26. Plasminogen activator inhibitor-1
27. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: A gene targeting and gene transfer study in mice
28. Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin
29. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury
30. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice
31. Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1
32. Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries
33. Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening